The specialist IP commercialisation group reports that a vaccine candidate developed by its portfolio company has outperformed an existing commercial vaccine in trials.
The asset management firm has increased its stake in the intellectual property commercialization company.
The asset management firm has disclosed a change in its shareholding in Frontier IP Group Plc.
The asset management firm has announced changes to its major shareholdings.
The asset management firm has increased its stake in the intellectual property commercialization company.
The retailer has announced details of its directors' shareholdings following a recent fundraising.
The specialist in commercialising intellectual property has successfully completed a retail offer, raising £174,117 through the issue of 1,123,338 shares at a 3.125% discount to the previous closing price.
The clean technology company Dekiln, a portfolio investment of Frontier IP, has been awarded £3 million in funding from the Royal Academy of Engineering to scale up its kiln-free tile technology to industrial production.
The specialist intellectual property commercialisation company has raised approximately £870,000 through a placing and subscription of new shares.
The asset management firm announces a retail offer of new shares at a modest 3.1% discount to the previous closing price, suggesting moderate investor appetite.